San Diego-based Metabolife pleads guilty to falsifying tax returns

By Hubert Vigilla

Published on October 06, 2005

According to Metabolife attorney Robert Humphreys, the bankrupt company failed to report income of more than $1 million in 1997 and 1998. By understating income, Metabolife avoided payment of more than $339,000 to the Internal Revenue Service.

Metabolife is currently facing a number of other legal problems, the most serious of which involves federal charges of lying to the Food and Drug Administration about the health risks of Metabolife 356, the company's flagship, ephedra-based product. An estimated 155 deaths from strokes, heart attacks and other serious injuries have been linked to Metabolife 365.

Comment on this article →

Share |

Keyword Tags: pharmaceutical litigation, diet drugs, ephedra

Post your comment

Public comments are welcome. For answers to your personal questions, ask an attorney in our directory.

Name
Email (kept private)
Website
Message